BLT - Blis Technologies

[simla]

The news doesn't come much better than this. The CEO has too much to do, reinforcements on the way.. https://nzx.com/companies/BLT/announcements/254616

[simla]

Sadly, Blis is turning into a successful company! It just won't be the same when (if) it completes that transition. Still, there will be the whole new adventure of finding out just how much they hope to grow once they have cash flow to play with. I'm not expecting them to slow down personally.

[simla]

... The Moose, at his request asked me to delete his account along with all his posts ...

To avoid confusion since he posted here fairly often, I thought it might be helpful to link to this report that Moosie has left for some reason, and his posts seem to have gone too. Good hunting, Moosie. Live long and prosper.

[Minerbarejet]

Prominent display of Blis Products in the local Unichem Pharmacy. Enquired as to how popular they were and was told that people are most impressed with them especially the throat guard and sales are really picking up. So word is getting out there. All good

[skid]

anyone know how they are doing in other countries?

[GTM 3442]

profit takers pushing the sp down?

More like a vast reservoir of shareholders who will regard anything over 2c as a chance to take some profit.

A lot of those to chew through before the share price gets any real traction.

[simla]

Maybe. But the half-year is out in about two months now, just a few weeks. While there is no reason to expect an avalanche of increased sales, neither is there any reason to expect no good news. Just stocking up those 600 pharmacies in China would be a bit when you consider they probably all have good foot traffic around. And the American market has been in place for a bit now, so recovery there could be reasonably noticeable. Unfortunately there is no way for us of knowing what impact these food products will have on revenue, not least as we do not know how many forward sales are already lined up, if any.

Don't forget the Stuff article, "The new funds are expected to see the company through until it hits its forecast profitability next year." ... compared to the loss of $1.54m last year. That's projecting quite a jump in revenue, I'd have thought, so something has to move between then and soon. Since that loss, we've had the dairy complex open for business, 600 pharmacies in China, Nekta Blis, the US market opening back up, some new products and formats, and reports of increasing sales in Europe and Asia.

Sell now? Yeah, but you'd have to be fairly confident nothing good was about to show up? Just my opinion obviously. That argument may be true for a few years yet, so when does anyone take their profit? Don't know.

[Minerbarejet]

further articles recently released
BLIS Probiotic Aids Oral Health

Yesterday0 Comments
Posted in News, Industry News, Probiotics, Clinical Research, Oral Health

Print
ST.CHARLES, Mo.—BLIS^® M18, a branded Streptococcus salivarius M18 probiotic from BLIS Technologies Ltd., can provide enhanced benefits for maintaining the health of the oral cavity. (Journal of Nutritional Science. 2013, Dec; Online. DOI: 10.1017/jns.2013.35)




New research was carried out in a collaboration between Western University (London, Ontario) and BLIS Technologies (Dunedin, New Zealand), which demonstrated that daily dosing with a single lozenge of BLIS M18 resulted in a greater than 80 percent (100 million probiotic/lozenge) and 90 percent (1 billion probiotic/lozenge), respectively, of individuals (healthy young adults) having detectable levels of the probiotic after seven days of administration.
This is a marked improvement over previous BLIS M18 research using an earlier formulation (3.6 billion probiotic/lozenge), in which only 22 percent of school children had detectable salivary levels of BLIS M18 following three months of twice daily consumption. Despite these comparatively lower levels of probiotic persistence in the earlier placebo-controlled trial, a significant reduction in plaque formation was observed over the three months of the trial.
BLIS M18 supports oral health because it produces and secretes several beneficial substances, including those that specifically target and inhibit oral pathogens such as Streptococcus mutans, bacteria that contribute to the development of dental caries. To be most effective, BLIS M18 must remain in the oral cavity for a sufficient duration to allow the production of these substances and the subsequent inhibition of undesirable bacteria. Burton and colleagues reported a downward trend in S. mutans levels in volunteers who had detectable levels of BLIS M18 in their saliva. The improved persistence demonstrated in this latest trial indicates that the updated BLIS M18 formulation will result in a greater level of S. mutans reductions.
In addition to expanding current knowledge regarding the efficacy of BLIS M18, the safety is also supported by this study. The effect on the normal healthy oral microbiome of a sub-set of subjects was assessed via the use of total 16S RNA analysis of total salivary microbiota. The results indicated that there were no significant ecological shifts in the microbiota following the probiotic dosing, supporting that BLIS M18 colonization does not contribute to a non-specific disruption of indigenous microbiota in the oral cavity of healthy adults.

Also
http://www.nutraingredients-usa.com/...health-benefit

[emearg]

Don't forget the Stuff article, "The new funds are expected to see the company through until it hits its forecast profitability next year." ... compared to the loss of $1.54m last year. That's projecting quite a jump in revenue, I'd have thought, so something has to move between then and soon. Since that loss, we've had the dairy complex open for business, 600 pharmacies in China, Nekta Blis...

Don't forget that newspapers usually get half the facts wrong so until NektaBlis becomes publicly visible I'm not counting that chicken. Heck, this article got a key fact wrong. After a successful trial in three stores? Ummm no.

I wait with baited breath for a juice product. It will be excellent progress if it comes to fruition. At that point I will start thinking of it is terms of building revenue rather than just as an expense which it presumably is at the moment i.e. associated development costs

[emearg]

further articles recently released
BLIS Probiotic Aids Oral Health

Yesterday0 Comments
Posted in News, Industry News, Probiotics, Clinical Research, Oral Health

Print
ST.CHARLES, Mo.—BLIS^® M18, a branded Streptococcus salivarius M18 probiotic from BLIS Technologies Ltd., can provide enhanced benefits for maintaining the health of the oral cavity. (Journal of Nutritional Science. 2013, Dec; Online. DOI: 10.1017/jns.2013.35)




New research was carried out in a collaboration between Western University (London, Ontario) and BLIS Technologies (Dunedin, New Zealand), which demonstrated that daily dosing with a single lozenge of BLIS M18 resulted in a greater than 80 percent (100 million probiotic/lozenge) and 90 percent (1 billion probiotic/lozenge), respectively, of individuals (healthy young adults) having detectable levels of the probiotic after seven days of administration.
This is a marked improvement over previous BLIS M18 research using an earlier formulation (3.6 billion probiotic/lozenge), in which only 22 percent of school children had detectable salivary levels of BLIS M18 following three months of twice daily consumption. Despite these comparatively lower levels of probiotic persistence in the earlier placebo-controlled trial, a significant reduction in plaque formation was observed over the three months of the trial.
BLIS M18 supports oral health because it produces and secretes several beneficial substances, including those that specifically target and inhibit oral pathogens such as Streptococcus mutans, bacteria that contribute to the development of dental caries. To be most effective, BLIS M18 must remain in the oral cavity for a sufficient duration to allow the production of these substances and the subsequent inhibition of undesirable bacteria. Burton and colleagues reported a downward trend in S. mutans levels in volunteers who had detectable levels of BLIS M18 in their saliva. The improved persistence demonstrated in this latest trial indicates that the updated BLIS M18 formulation will result in a greater level of S. mutans reductions.
In addition to expanding current knowledge regarding the efficacy of BLIS M18, the safety is also supported by this study. The effect on the normal healthy oral microbiome of a sub-set of subjects was assessed via the use of total 16S RNA analysis of total salivary microbiota. The results indicated that there were no significant ecological shifts in the microbiota following the probiotic dosing, supporting that BLIS M18 colonization does not contribute to a non-specific disruption of indigenous microbiota in the oral cavity of healthy adults.

Also
http://www.nutraingredients-usa.com/...health-benefit

Try:
http://www.nutraingredients-usa.com/...ealth-benefits

I got several google alerts about this report. Is all over the internet. Not too sure why considering the study was done and published a year ago? No matter...is good news. Great to see the efficacy of M18 is being improved. It will need to be highly efficacious (like K12 is) if it is going to make it into food and drink products.